makeO raises $16 million
Our partner company makeO is India’s leading provider of clear aligner and cosmetic dermatology solutions.

makeO has raised USD16 million (INR 135 crores) in a round led by 360 ONE Asset and prominent public market investor Ashish Kacholia. The round saw continued participation from South Korea based Paramark Ventures, the family office of Medlife’s co-founders – Prashant Singh and Tushar Kumar, along with participation from our India Ventures Team.

The funds will be used to democratise access to clinical grade smile, skin and hair treatment solutions across India. Additionally, makeO intends to use the raised funds to support the company's plans to broaden its geographic footprint by establishing experience centres, which offer customers a physical touchpoint to consult with orthodontists and dermatologists.

Speaking about the fundraise, Dr. Arpi Mehta, Founder & CEO, makeO said, "Our mission is to ensure that clinical-grade makeovers are more accessible, affordable and convenient to every Indian. This fundraise is a testament to the trust our investors have in our ability to execute on this vision. The capital will enable us to strengthen our online and offline footprint, offering customers the convenience of accessing our services at their doorstep or through either our physical experience centers.”

makeO has served over 150,000 customers across its portfolio of offerings, which in addition to clear aligners and laser hair reduction, also includes acne removal, anti-ageing, teeth whitening and dental hygiene products. At the heart of makeO’s tech-driven approach is a specialized mobile app facilitating remote consultations and monitoring by in-house orthodontists, dentists, and dermatologists for a truly seamless experience. This is supported by a strong offline ecosystem of over 100 in-house orthodontists, dentists, and dermatologists, over 25 flagship experience centers (across top cities including Mumbai, Delhi, Bangalore, Hyderabad, Chennai and Pune) and 400 partner dental clinics.

Read more about the fundraise here.